Ketamine-assisted treatment is often discussed in terms of mood, relief, or altered experience. CRT-K asks a different question: how might ketamine-assisted work and structured cognitive remediation be brought together when cognitive rigidity, attention, memory, or flexibility are part of the clinical picture? At Acheron Psychiatry, Ketamine-Assisted Cognitive Remediation Therapy is not ketamine alone, and it is not cognitive training alone; it is a structured clinical integration of both.
What CRT-K Means at Acheron Psychiatry
Ketamine-Assisted Cognitive Remediation Therapy, or CRT-K, combines ketamine-assisted therapeutic work with Cognitive Remediation Therapy. Cognitive Remediation Therapy, or CRT, is a structured clinical approach that helps patients practice cognitive strategies and work directly with cognitive skills such as attention, memory, planning, problem-solving, and cognitive flexibility.
Cognitive flexibility is the ability to shift perspective, adjust to new information, and move between different mental strategies. For some patients, that kind of flexibility is not only a cognitive concern. It may also be emotional, relational, and defensive. A person can become stuck in a thought loop, a familiar conclusion, a self-protective posture, or a way of organizing experience that once made sense but no longer serves the life they are trying to live.
At Acheron Psychiatry, CRT-K is offered as a structured treatment course. The protocol includes 14 sessions: four preparation sessions, four ketamine medicine sessions, four integration sessions, and two additional non-ketamine sessions. This structure matters. CRT-K is not a single ketamine session with cognitive exercises attached. It is a treatment frame designed to help patients approach cognition, mood, and meaning in a more organized way.
Psychiatry, psychotherapy, cognitive remediation, preparation, and integration are all offered within the same clinical setting, allowing patients to receive care within a coordinated treatment model rather than across multiple providers.
Because CRT-K brings together more than one clinical approach, precision matters. We can speak clearly about the component parts without pretending the combined model is more established than it is. The treatment draws from established work in cognitive remediation, developing research on ketamine-assisted psychotherapy, and ongoing study of ketamine’s cognitive effects.
Why Cognitive Function Matters in Mental Health
Cognitive symptoms can be easy to misread. A person may think they are lazy when they are cognitively overloaded. They may think they lack discipline when they are struggling with initiation, working memory, organization, or flexibility. They may think they have no insight when the problem is that insight does not translate into action.
Concerns such as depression, anxiety, trauma, ADHD, chronic stress, post-concussive symptoms, traumatic brain injury, and long COVID-related cognitive changes may all affect how a person thinks, shifts, plans, remembers, and follows through. The appropriate treatment path depends on clinical evaluation, but the pattern is familiar: the mind becomes less available to itself.
A patient may feel trapped not only by mood, but by the shape of thought itself. The same loop. The same feared outcome. The same inability to shift. The same conclusion reached before the present situation has been fully taken in.
Research on cognitive remediation has described it as a therapeutic approach used to address cognitive difficulties across psychiatric disorders (Kim et al., 2018). In depression specifically, meta-analytic research has found short-term improvement in cognitive functioning, while also noting that effects on depressive symptoms and daily functioning may be more complex and should not be overstated (Legemaat et al., 2021). That balance is important. Cognitive work may matter deeply without becoming a cure-all.
Where Ketamine Fits, and Where It Does Not
Ketamine can produce changes in perception, bodily awareness, emotion, and the relationship to thoughts or memories. In some patients, a ketamine-assisted session may create a temporary opening in the usual structure of experience. A thought may feel less absolute. A defensive position may become more visible. A rigid conclusion may loosen enough to be questioned.
But ketamine should not be treated as a simple cognitive enhancer. That would be too reductive and too strong. For Acheron Psychiatry, the more careful question is not whether ketamine improves thinking in a general way. The question is whether a ketamine-assisted state, held inside a structured therapeutic and cognitive remediation frame, may create conditions where certain patterns can be noticed, practiced with, and integrated differently.
That is why CRT-K has to be discussed with precision. Ketamine may create an opening for some patients. CRT gives structure to the work. Integration asks how the material becomes usable. None of these pieces should be treated as sufficient on their own.
How CRT-K Differs From KAP Alone
Ketamine-assisted psychotherapy, or KAP, places ketamine inside a psychotherapeutic process that includes preparation, medically supervised medicine sessions, and integration. KAP may focus on emotional material, trauma, defenses, relational patterns, unconscious themes, grief, meaning, and the patient’s inner life as it emerges through the treatment process.
CRT-K shares that respect for preparation and integration, but it adds a more explicit cognitive focus. The treatment is not only asking what the experience means. It is also asking how the patient thinks, shifts, organizes, remembers, plans, recovers from mistakes, and meets mental difficulty.
A patient may have insight into a pattern and still feel unable to interrupt it. They may understand that a conclusion is old, but still return to it. They may recognize that a response is defensive, but feel unable to create enough space to choose differently. CRT-K is designed to bring structured cognitive work into that gap between insight and flexibility.
This does not mean CRT-K is better than KAP, or that every patient who is interested in ketamine-assisted therapy should choose CRT-K. KAP and CRT-K may serve different needs depending on the person’s symptoms, cognitive concerns, treatment history, and goals.
What CRT-K Can Help Patients Explore
CRT-K may be considered when cognitive rigidity, attention difficulty, memory concerns, executive function challenges, or difficulty shifting perspective are part of the clinical picture. Executive function refers to mental skills involved in planning, organizing, initiating tasks, monitoring behavior, and adapting to changing demands.
For some patients, the difficulty is not lack of awareness. It is that the same cognitive and emotional pattern keeps winning. The person may know they are catastrophizing, but still feel captured by the catastrophic conclusion. They may know they are avoiding, but still cannot begin. They may know the old story is not the whole truth, but still experience it as the only available truth.
CRT-K creates a frame for working with those patterns directly. The ketamine-assisted portion may allow some patients to encounter familiar material from a different angle. The CRT portion brings structure, practice, and observation to how the mind responds. The integration work helps connect what emerges to the patient’s daily life, relationships, symptoms, and ongoing treatment.
Studies of possible mechanisms in ketamine-assisted psychotherapy have discussed neurobiological effects, shifts in perspective, psychotherapy, and other factors that may contribute to treatment outcomes, while also emphasizing that evidence remains limited and further research is needed (Joneborg et al., 2022). That caution belongs in this conversation. CRT-K should be approached as a thoughtful clinical model, not as a guaranteed way to change cognition.
Who CRT-K May Be Appropriate For
CRT-K may be considered for some adults whose mental health concerns include cognitive rigidity, attentional difficulty, executive function challenges, or a sense of being caught in repetitive cognitive and emotional loops. These concerns may appear alongside depression, PTSD, anxiety, ADHD, bipolar disorder, or other concerns Acheron evaluates and treats, but CRT-K is not appropriate for every patient.
Clinical evaluation matters. A patient’s psychiatric history, medical history, current symptoms, medications, supports, mood stability, treatment goals, and safety considerations all matter before ketamine-assisted work is considered. For some patients, standard CRT may be the better starting point. For others, psychotherapy, medication management, neuropsychological assessment, KAP, or another form of care may be more appropriate.
For patients with bipolar disorder, careful evaluation is especially important. Mood stability, current symptoms, medication history, and risk factors should be reviewed before any ketamine-assisted approach is considered. The goal is not to move quickly toward the most intensive option. The goal is to understand what kind of clinical frame can safely meet the person’s needs.
Off-Label Use, Safety, and Evidence Limits
Racemic ketamine, as used in ketamine-assisted psychotherapy and CRT-K, is not FDA-approved to treat depression, PTSD, anxiety, bipolar disorder, ADHD, or cognitive symptoms associated with psychiatric conditions. Ketamine-assisted approaches for psychiatric conditions are off-label uses of ketamine. Off-label treatment decisions should be made carefully and only under the supervision of qualified medical providers.
This matters especially for CRT-K because the source base is not the same for every part of the treatment. CRT has its own research base. Ketamine-assisted psychotherapy has a developing research base. Ketamine and cognition have been studied, especially in treatment-resistant depression. CRT-K as a combined clinical integration should be discussed with more caution than any one component.
That caution is not a disclaimer against the work. It is part of responsible clinical care. Results vary by individual, and no patient should be told that CRT-K will improve cognition, cure depression, resolve trauma, or produce a specific outcome. The more responsible promise is a process: careful evaluation, thoughtful preparation, medically supervised treatment when appropriate, structured cognitive work, and integration.
Cost, Scheduling, and Fear of an Unfamiliar Treatment
CRT-K is less familiar to most patients than therapy, medication management, or standard KAP. That unfamiliarity can create hesitation. Some patients may wonder whether the treatment is too intensive. Others may worry that ketamine will dominate the process, that cognitive work will feel exposing, or that they will be expected to perform well during treatment.
Those concerns are clinically relevant. A person’s relationship to performance, control, failure, dependence, and uncertainty may be part of the very material that treatment needs to respect. CRT-K is not designed to test whether a patient is smart, capable, or trying hard enough. It is designed to create a structured setting where patterns of thought, flexibility, avoidance, and recovery can be worked with carefully.
Because costs and coverage may vary by service and treatment plan, we encourage patients to discuss financial questions with our care coordination team before beginning. Acheron Psychiatry is in-network with Aetna and Cigna for eligible services. For out-of-network patients, we provide superbills, and some patients may receive partial reimbursement once their deductible is met. HSA and FSA funds are accepted, and limited sliding scale availability may be considered case by case.
Patients can begin with a complimentary phone consultation to explore their options, ask practical questions, and discuss whether evaluation for CRT-K, CRT, neuropsychological assessment, KAP, psychotherapy, or medication management may be an appropriate next step.
Frequently Asked Questions
What is CRT-K?
CRT-K stands for Ketamine-Assisted Cognitive Remediation Therapy. At Acheron Psychiatry, it refers to a structured clinical integration of ketamine-assisted work and Cognitive Remediation Therapy, with preparation, ketamine medicine sessions, integration, and non-ketamine sessions built into the treatment course.
Is CRT-K the same as KAP?
No. KAP, or ketamine-assisted psychotherapy, places ketamine inside a psychotherapeutic process. CRT-K includes that ketamine-assisted frame but adds a more explicit focus on cognition, cognitive flexibility, executive function, attention, and the way a patient works with mental difficulty.
Does ketamine improve cognition?
Ketamine should not be described as a simple cognitive enhancer. Some research has examined cognitive effects of ketamine and esketamine, especially in treatment-resistant depression, but the findings do not mean that ketamine reliably improves cognition for every patient. Researchers are increasingly interested in ketamine’s effects on neuroplasticity, the brain’s ability to adapt and form new connections. These effects may help explain why some patients report greater flexibility, insight, or shifts in perspective. However, the link between neuroplasticity, cognition, and clinical outcomes is still being studied. CRT-K should be discussed with a provider as a structured clinical integration, not as a guaranteed cognitive improvement treatment.
Who may be a candidate for CRT-K?
CRT-K may be considered for some adults whose mental health concerns include cognitive rigidity, attentional difficulty, executive function challenges, or repetitive cognitive and emotional patterns. It is not right for every patient, and evaluation should include psychiatric history, medical history, mood stability, current symptoms, medications, safety considerations, and treatment goals.
What does the CRT-K process involve?
The confirmed CRT-K protocol at Acheron Psychiatry includes 14 sessions: four preparation sessions, four ketamine medicine sessions, four integration sessions, and two additional non-ketamine sessions. The exact clinical fit should be discussed with a provider before beginning.
Key Takeaways
- CRT-K is not ketamine alone and not cognitive training alone. It is Acheron Psychiatry’s structured clinical integration of ketamine-assisted work and Cognitive Remediation Therapy.
- The evidence supports the component parts more strongly than the combined CRT-K model. CRT-K should be discussed carefully and without guaranteed claims.
- Ketamine should not be described as a simple cognitive enhancer. Research on ketamine, esketamine, and cognition is nuanced and does not support broad promises of cognitive improvement.
- CRT-K may be considered when cognitive rigidity, attention difficulty, executive function challenges, or repetitive cognitive-emotional patterns are part of the clinical picture.
- Results vary by individual. CRT-K and other ketamine-assisted approaches should be discussed with a qualified provider who understands your full clinical history.
Conclusion
CRT-K begins with the recognition that being stuck is not always only emotional, and it is not always only cognitive. Sometimes the pattern lives in the relationship between mood, thought, memory, defense, and flexibility. At Acheron Psychiatry, we offer complimentary phone consultations to help you explore your options and discuss whether CRT-K, CRT, neuropsychological assessment, KAP, psychotherapy, or another form of care may be an appropriate fit.
References
Gill, H., Gill, B., Rodrigues, N. B., Lipsitz, O., Rosenblat, J. D., El-Halabi, S., Nasri, F., Mansur, R. B., Lee, Y., & McIntyre, R. S. (2021). The effects of ketamine on cognition in treatment-resistant depression: A systematic review and priority avenues for future research. Neuroscience & Biobehavioral Reviews, 120, 78–85. https://pubmed.ncbi.nlm.nih.gov/33242561/
Joneborg, I., Lee, Y., Di Vincenzo, J. D., Ceban, F., Meshkat, S., Lui, L. M. W., Fancy, F., Rosenblat, J. D., & McIntyre, R. S. (2022). Active mechanisms of ketamine-assisted psychotherapy: A systematic review. Journal of Affective Disorders, 315, 105–112. https://pubmed.ncbi.nlm.nih.gov/35905796/
Kim, E. J., Bahk, Y.-C., Oh, H., Lee, W.-H., Lee, J.-S., & Choi, K.-H. (2018). Current status of cognitive remediation for psychiatric disorders: A review. Frontiers in Psychiatry, 9, 461. https://pmc.ncbi.nlm.nih.gov/articles/PMC6178894/
Legemaat, A. M., Semkovska, M., Brouwer, M., Geurtsen, G. J., Burger, H., Denys, D., Bockting, C. L. H., & Mocking, R. J. T. (2021). Effectiveness of cognitive remediation in depression: A meta-analysis. Psychological Medicine, 52(16), 4146–4161. https://pmc.ncbi.nlm.nih.gov/articles/PMC9811271/
Souza-Marques, B., Mota, N. B., Murru, A., Hidalgo-Mazzei, D., Vieta, E., Rosa, A. R., & Tabarés-Seisdedos, R. (2021). Neurocognitive effects of ketamine and esketamine for treatment-resistant major depressive disorder: A systematic review. Harvard Review of Psychiatry, 29(6), 340–350. https://pubmed.ncbi.nlm.nih.gov/34366408/
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine-Assisted Cognitive Remediation Therapy, Cognitive Remediation Therapy, ketamine-assisted psychotherapy, neuropsychological assessment, medication management, psychotherapy, and other mental health treatments should only be considered with guidance from a qualified provider who has reviewed your full medical and psychiatric history. Ketamine-assisted approaches for psychiatric conditions are off-label uses of racemic ketamine, and racemic ketamine is not FDA-approved to treat depression, PTSD, anxiety, bipolar disorder, ADHD, or cognitive symptoms associated with psychiatric conditions. Individual results vary. If you are experiencing a mental health crisis, thoughts of self-harm, or thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.
